Epstein-Barr Virus Research Today is a free monthly online journal that collates and summarizes the latest research about Epstein-Barr Virus, including details on ebv, infectious mononucleosis, glandular fever, chronic fatigue.

Volume 4 (2008), Issue 1 (January)

1. Epstein-Barr virus reactivation and multiple sclerosis.
   Eur J Neurol, 15(1): 106-8. [Abstract] [Full-text]
2. Tight regulation of the Epstein-Barr virus setpoint: interindividual differences in Epstein-Barr virus DNA load are conserved after HIV infection.
   Clin Infect Dis, 46(2): 313-6. [Abstract] [Full-text]
3. Epstein-Barr virus genotypes in multiple sclerosis.
   Acta Neurol Scand, 117(2): 141-4. [Abstract] [Full-text]
4. Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients.
   J Heart Lung Transplant, 27(1): 100-5. [Abstract] [Full-text]
5. Quantification of Epstein-Barr virus-DNA load in lung transplant recipients: a comparison of plasma versus whole blood.
   J Heart Lung Transplant, 27(1): 7-10. [Abstract] [Full-text]
6. Phase I trial of a CD8+ T-cell peptide epitope-based vaccine for infectious mononucleosis.
   J Virol, 82(3): 1448-57. [Abstract] [Full-text]
7. Monitoring of Epstein-Barr virus load after hematopoietic stem cell transplantation for early intervention in post-transplant lymphoproliferative disease.
   J Med Virol, 80(3): 441-54. [Abstract] [Full-text]
8. A new animal model for primary and persistent Epstein-Barr virus infection: human EBV-infected rabbit characteristics determined using sequential imaging and pathological analysis.
   J Med Virol, 80(3): 455-66. [Abstract] [Full-text]
9. Antibodies against malaria and Epstein-Barr virus in childhood Burkitt lymphoma: a case-control study in Uganda.
   Int J Cancer, 122(6): 1319-23. [Abstract] [Full-text]
10. Adhesion of Epstein-Barr virus-positive natural killer cell lines to cultured endothelial cells stimulated with inflammatory cytokines.
    Clin Exp Immunol, 151(3): 519-27. [Abstract] [Full-text]
11. Autorepression of Epstein-Barr virus nuclear antigen 1 expression by inhibition of pre-mRNA processing.
    J Virol, 82(4): 1679-87. [Abstract] [Full-text]
12. Epstein-Barr virus latent membrane protein 1 induces cellular MicroRNA miR-146a, a modulator of lymphocyte signaling pathways.
    J Virol, 82(4): 1946-58. [Abstract] [Full-text]
13. Latent membrane protein 2B regulates susceptibility to induction of lytic Epstein-Barr virus infection.
    J Virol, 82(4): 1739-47. [Abstract] [Full-text]

© 2005-2008 Epstein-Barr Virus Research Today. All Rights Reserved.